January 16, 2026

Where CAPA Actually Sits: Complaints → Design → CMOs

CAPA Survival Playbooks — Kandih Bioscience CAPA does not sit in QA.From an FDA inspection perspective, CAPA sits at the intersection of complaints, design controls, supplier/CMO […]
January 15, 2026

Where Do Your CAPAs Originate Most?

CAPA Survival Playbooks — Kandih Bioscience CAPAs Don’t Fail at Closure—They Fail at the Source Most CAPA programs don’t fail because teams can’t write corrective actions.They […]
January 14, 2026

CAPA ≠ Paperwork. It’s a Risk-Control Feedback Loop

CAPA Survival Playbooks — Kandih Bioscience One of the most common inspection surprises plays out the same way every time:the CAPA file is immaculate—signed, dated, closed […]
January 13, 2026

CAPA Failures as Evidence of a Broken Risk-Control System

(How FDA documents system collapse, not paperwork gaps) FDA consistently uses CAPA failures as proxy evidence that a firm’s end-to-end risk-control architecture is nonfunctional. For medical […]
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.and Cookie policy
Read more
💬

Chat with us